期刊文献+

基于多随机经验核的弥漫大B细胞淋巴瘤复发预测

Precise Prediction of Diffuse Large B-Cell Lymphoma based on Multiple Random Empirical Kernel Learning Machine
下载PDF
导出
摘要 目的基于多随机经验核分类器构建弥漫大B细胞淋巴瘤完全缓解后两年内复发情况的预测模型,为患者的治疗提供决策依据。方法利用山西省某三甲医院2010-2020年电子病历库中符合本研究要求的445名患者信息,基于五种常见类别不平衡处理方法以及多随机经验核分类器构建复发预测模型,并与五种分类器进行比较。结果基于SMOTE Tomek Links+多随机经验核分类器的复发预测模型取得了最优的分类性能(accuracy=0.89,precision=0.87,recall=0.92,f1-Score=0.89,brier score=0.11)。结论对DLBCL实际数据集,本文使用SMOTE Tomek links处理不平衡数据并构建多随机经验核模型,模型性能达到最优的同时计算复杂度也不高,可为DLBCL复发预测提供有力参考。 Objectives To construct a prediction model of relapse in diffuse large B-cell lymphoma within two years after complete remission based on multiple randomized empirical kernel learning machine to provide a basis for patient treatment decisions.Methods Using the information of 445 patients who met the requirements of this study in the electronic medical record database of a tertiary hospital in Shanxi Province from 2010 to 2020,a relapse prediction model was constructed based on five common categories of imbalance treatment methods and a multiple stochastic empirical kernel learning machine,and compared with the five classifiers.Results The recurrence prediction model based on SMOTE Tomek Links+multiple randomized empirical kernel learning machine achieved optimal classification performance(accuracy=0.89,precision=0.87,recall=0.92,f1-Score=0.89,brier score=0.11).Conclusion For the actual DLBCL dataset,in this paper,we used SMOTE Tomek links to process the imbalance data and construct a multiple randomized empirical kernel learning machine,which achieves the optimal model performance with low computational complexity and can provide a powerful reference for DLBCL recurrence prediction.
作者 李雪玲 赵艳琳 张岩波 余红梅 周洁 李琼 王俊霞 乔宇 张高源 赵志强 罗艳虹 Li Xueling;Zhan Yanlin;Zhang Yanbo(Department of Health Statistics,School of Public Health,Shanxi Medical University(030001),Taiyuan)
出处 《中国卫生统计》 CSCD 北大核心 2024年第3期339-343,共5页 Chinese Journal of Health Statistics
基金 山西省科技厅应用基础研究计划面上项目(202103021224245) 国家自然科学基金青年科学基金(81502897,82273742) 山西医科大学博士启动基金(BS2017029)。
关键词 弥漫大B细胞淋巴瘤 复发预测 经验核映射 类别不平衡 Diffuse large B-cell lymphoma Recurrence prediction Empirical kernel mapping Category imbalance
  • 相关文献

参考文献4

二级参考文献43

  • 1Korl AD, le Gessie S, Snijder S, et al. Primary extranodal non- Hodgkin' s lymphoma (NHL): the impact of alternative defini- tions tested in the Comprehensive Cancer Centre West popula- tion-based NHL registry. Ann Oncol, 2003, 14:131-139.
  • 2Li XQ, Li GD, Gao ZF, et al. The relative frequencies of lympho- ma subtypes in China: a nationwide study of 10002 cases by the Chinese Lymphoma Study Group. Ann Oncol, 2011, 22 Suppl 4: ivl41.
  • 3Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a stan- dard regimen (CHOP) with three intensive chemotherapy regi- mens for advanced non-Hodgkin' s lymphoma. N Engl J Med, 1993, 328:1002-1006.
  • 4Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med, 2005, 352:1197-1205.
  • 5Coiffier B, Thieblemont C, Van Den Neste E,et ah Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemother- apy in DLBCL patients: a study by the Grouped' Etudes des Lymphomes de 1' Adulte. Blood, 2010, 116:2040-2045.
  • 6Seki R, Ohshima K, Nagafuji K, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol, 2010, 9 I: 258-266.
  • 7Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 2005, 23:5027-5033.
  • 8Habermama TM, Weller EA, Morrison VA, et al. Rituximab- CHOP versus CHOP alone or with maintenance rituximab in old- er patients with diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:3121-3127.
  • 9Tilly H, Dreyling M. ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin' s lymphoma: ESMO clinical recom- mendations for diagnosis, treatment and follow-up. Ann Oncol, 2008, Suppl 2:ii67-69.
  • 10NCCN Guidelines. Non-Hodgkin' s Lymphomas, version 2.2012.

共引文献257

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部